Short answer
AdaptHealth Corp. (AHCO) filed its Q1 2026 10-Q quarterly report on May 5, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $820M (up 5.4% year over year) with net income of −$16M.
Q1 2026 key financials · XBRL
- Revenue
- $820M
- +5.4% YoY
- Net income
- −$16M
- −122.6% YoY
- Operating margin
- 0.7%
- EPS (diluted)
- −$0.12
- −140.0% YoY
Source: XBRL data from the AdaptHealth Corp. (AHCO) Q1 2026 10-Q on SEC EDGAR. USD.
AdaptHealth Corp. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $819.8M, up 5.4% YoY from $777.9M
- Operating margin 0.7% vs 3.0%; Adjusted EBITDA margin 14.8% vs 16.4%
- Sleep Health largest segment: revenue $358.5M, up 13.3%; Wellness at Home weakest: $141.0M, down 10.3%
- Respiratory Health strongest EBITDA growth: $50.0M, up 10.0%; Wellness EBITDA $4.3M vs $12.4M
- Inflationary costs, labor pressure, dispositions, and seasonal early-year demand headwinds; no updated guidance disclosed
Risk Factors
- New regulatory risk: CMS announced a 6-month nationwide moratorium on Medicare enrollment for certain DMEPOS medical supply companies
- Growth risk: Moratorium could block new locations, acquisitions, or ownership-change re-enrollments requiring new supplier enrollment
- Compliance risk: Enhanced CMS screening may involve site visits, verification activities, audits, and enrollment denials
- Operational risk: CMS extensions or expansion to additional supplier categories could delay growth initiatives and increase administrative burden
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other AdaptHealth Corp. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.